New pill combo aims to fight advanced kidney cancer
NCT ID NCT07489495
First seen Jun 25, 2026 · Last updated Aug 14, 2026 · Updated 11 times
Summary
This Phase 3 trial is testing whether adding the drug zanzalintinib to belzutifan helps people with advanced kidney cancer live longer and keep the cancer from growing. About 758 participants who have already tried standard treatments will receive either the combination or belzutifan alone. The study is currently recruiting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- belzutifan and zanzalintinib (targeted therapy pills)
- What this could lead to
- If successful, this combination could offer a new treatment option for people with advanced kidney cancer who have run out of standard therapies, potentially helping them live longer and delay cancer growth.
- What could go wrong
- This is an early-stage Phase 3 trial, so results are not guaranteed. The combination may not work better than belzutifan alone, and side effects from adding zanzalintinib could be more severe.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED RENAL CELL CARCINOMA WITH CLEAR CELL COMPONENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
AIDPORT Sp. z o.o. ( Site 2118)
RECRUITINGSkórzewo, Greater Poland Voivodeship, 60-185, Poland
-
AO Santa Maria della Misericordia ( Site 1805)
RECRUITINGPerugia, 06132, Italy
-
ATTIKON GENERAL UNIVERSITY HOSPITAL ( Site 1401)
RECRUITINGAthens, Attica, 124 62, Greece
-
Aarhus Universitetshospital, Skejby ( Site 1001)
RECRUITINGAarhus, Central Jutland, 8200, Denmark
-
Adana Medical Park Seyhan Hastanesi ( Site 2505)
RECRUITINGAdana, 01140, Turkey (Türkiye)
-
Alexandra General Hospital of Athens ( Site 1400)
RECRUITINGAthens, Attica, 115 28, Greece
-
Ankara University Health Practice and Research Hospitals ( Site 2506)
RECRUITINGAnkara, 06620, Turkey (Türkiye)
-
Asan Medical Center ( Site 2901)
RECRUITINGSeoul, 05505, South Korea
-
Azienda Ospedaliera Universitaria Careggi ( Site 1807)
RECRUITINGFlorence, Tuscany, 50134, Italy
-
Bradfordhill ( Site 0400)
RECRUITINGSantiago, Region M. de Santiago, 8420383, Chile
-
CEDOES ( Site 0303)
RECRUITINGVitória, Espírito Santo, 29055-450, Brazil
-
CHU Angers ( Site 1204)
RECRUITINGAngers, Maine-et-Loire, 49933, France
-
CHU de Saint-Etienne ( Site 1202)
RECRUITINGSaint Priest En Jarez, Pays de la Loire Region, 42271, France
-
COE (Centro Oncológico de Excelencia) ( Site 0259)
RECRUITINGSan Juan, J5402BGA, Argentina
-
Centre Antoine Lacassagne ( Site 1209)
RECRUITINGNice, Alpes-Maritimes, 06189, France
-
Centro Oncologico Korben ( Site 0254)
RECRUITINGCABA, Buenos Aires, C1426AHB, Argentina
-
Centro Oncológico Riojano Integral ( Site 0256)
RECRUITINGLa Rioja, X5004BAL, Argentina
-
Centro Privado de RMI Río Cuarto S.A. II ( Site 0255)
RECRUITINGRío Cuarto, Córdoba Province, X5800ALB, Argentina
-
Charité Universitaetsmedizin Berlin - Campus Mitte ( Site 1312)
RECRUITINGBerlin, 10117, Germany
-
Clinique Victor Hugo Le Mans-Oncology-Radiotherapy ( Site 1203)
RECRUITINGLe Mans, Pays de la Loire Region, 72000, France
-
Clínica Puerto Montt ( Site 0404)
RECRUITINGPort Montt, Los Lagos Region, 5500243, Chile
-
Fakulti poliklinika ( Site 0906)
RECRUITINGPrague, 128 08, Czechia
-
Fakultni nemocnice Hradec Kralove ( Site 0902)
RECRUITINGHradec Králové, 500 05, Czechia
-
Fakultni nemocnice Ostrava ( Site 0904)
RECRUITINGOstrava, Ostrava Mesto, 708 52, Czechia
-
Fakultni nemocnice v Motole ( Site 0900)
RECRUITINGPrague, 150 06, Czechia
-
Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 1800)
RECRUITINGMilan, 20133, Italy
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 1801)
RECRUITINGRoma, 00168, Italy
-
Fundacion Arturo Lopez Perez ( Site 0401)
RECRUITINGSantiago, Region M. de Santiago, 7500921, Chile
-
Fundación Instituto Valenciano de Oncología ( Site 2307)
RECRUITINGValencia, 46009, Spain
-
Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0302)
RECRUITINGSão José do Rio Preto, São Paulo, 15090-000, Brazil
-
HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON ( Site 2301)
RECRUITINGMadrid, Madrid, Comunidad de, 28007, Spain
-
Hacettepe Universite Hastaneleri ( Site 2500)
RECRUITINGSıhhiye, Ankara, 06230, Turkey (Türkiye)
-
Haga Ziekenhuis locatie Leyweg ( Site 1906)
RECRUITINGThe Hague, South Holland, 2545 AA, Netherlands
-
Herlev Hospital ( Site 1002)
RECRUITINGHerlev, Capital Region, 2730, Denmark
-
Hope - Humanizacao Em Oncologia, Pesquisa E Ensino ( Site 0306)
RECRUITINGRibeirão Preto, São Paulo, 14026-610, Brazil
-
Hopital Europeen Marseille ( Site 1216)
RECRUITINGMarseille, Bouches-du-Rhone, 13003, France
-
Hospital Insular de Gran Canaria ( Site 2308)
RECRUITINGLas Palmas, 35016, Spain
-
Hospital Italiano de Buenos Aires ( Site 0253)
RECRUITINGCiudad de Buenos Aires, Buenos Aires, 1181, Argentina
-
Hospital Universitari Vall d'Hebron ( Site 2303)
RECRUITINGBarcelona, 08035, Spain
-
Hospital Universitario 12 de Octubre ( Site 2300)
RECRUITINGMadrid, 28041, Spain
-
Hospital Universitario Virgen del Rocio ( Site 2306)
RECRUITINGSeville, Andalusia, 41013, Spain
-
IC La Serena Research ( Site 0405)
RECRUITINGLa Serena, Coquimbo Region, 1720430, Chile
-
IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" ( Site 1809)
RECRUITINGMeldola, Emilia-Romagna, 47014, Italy
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola ( Site 1803)
RECRUITINGBologna, 40138, Italy
-
Institut Català d'Oncologia - L'Hospitalet ( Site 2305)
RECRUITINGL'Hospitalet de Llobregat, Barcelona, 08908, Spain
-
Instituto Alexander Fleming ( Site 0252)
RECRUITINGCABA, C1426ANZ, Argentina
-
Instituto de Investigaciones Clinicas Mar del Plata ( Site 0250)
RECRUITINGMar del Plata, Buenos Aires, B7600FZO, Argentina
-
Instituto de Oncología de Rosario ( Site 0257)
RECRUITINGRosario, Santa Fe Province, S2000KZE, Argentina
-
Instituto do Câncer e Transplante de Curitiba ( Site 0300)
RECRUITINGCuritiba, Paraná, 80510-130, Brazil
-
Istituto Clinico Humanitas ( Site 1808)
RECRUITINGRozzano, Milano, 20089, Italy
-
Istituto Nazionale Tumori Regina Elena ( Site 1804)
RECRUITINGRoma, 00144, Italy
-
Koc Universitesi Hastanesi ( Site 2501)
RECRUITINGIstanbul, 34010, Turkey (Türkiye)
-
LBM ONCOPOLE CLAUDIUS REGAUD ( Site 1215)
RECRUITINGToulouse, Haute-Garonne, 31059, France
-
Liga Norte Riograndense Contra o Câncer ( Site 0307)
RECRUITINGNatal, Rio Grande do Norte, 59062-000, Brazil
-
MTZ Clinical Research Powered by Pratia ( Site 2107)
RECRUITINGWarsaw, Masovian Voivodeship, 02-172, Poland
-
Maastricht UMC+ ( Site 1901)
RECRUITINGMaastricht, Limburg, 6229 HX, Netherlands
-
Macquarie University ( Site 2700)
SUSPENDEDMacquarie University, New South Wales, 2109, Australia
-
Masarykuv onkologicky ustav ( Site 0903)
RECRUITINGBrno, Brno-mesto, 656 53, Czechia
-
Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 2102)
RECRUITINGSiedlce, Masovian Voivodeship, 08-110, Poland
-
Meir Medical Center. ( Site 1603)
RECRUITINGKfar Saba, 4428164, Israel
-
Metropolitan Hospital ( Site 1402)
RECRUITINGAthens, Attica, 185 47, Greece
-
Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 2106)
RECRUITINGGliwice, Silesian Voivodeship, 44-102, Poland
-
Nederlands Kanker Instituut Antoni van Leeuwenhoek (NKI AVL) ( Site 1900)
RECRUITINGAmsterdam, North Holland, 1066 CX, Netherlands
-
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 0102)
RECRUITINGMarietta, Georgia, 30060, United States
-
ONCOCENTRO APYS ( Site 0403)
RECRUITINGViña del Mar, Valparaiso, 2520598, Chile
-
Peter MacCallum Cancer Centre ( Site 2702)
SUSPENDEDMelbourne, Victoria, 3000, Australia
-
Pratia MCM Krakow ( Site 2115)
RECRUITINGKrakow, Lesser Poland Voivodeship, 30-727, Poland
-
Rabin Medical Center ( Site 1602)
RECRUITINGPetah Tikva, 4941492, Israel
-
Rambam Health Care Campus ( Site 1600)
RECRUITINGHaifa, 3109601, Israel
-
Samsung Medical Center ( Site 2902)
RECRUITINGSeoul, 06351, South Korea
-
Sanatorio Parque ( Site 0251)
RECRUITINGRosario, Santa Fe Province, S2000DSV, Argentina
-
Severance Hospital, Yonsei University Health System ( Site 2903)
RECRUITINGSeoul, 03722, South Korea
-
Sheba Medical Center ( Site 1601)
RECRUITINGRamat Gan, 5265601, Israel
-
The Christie Hospital NHS Foundation Trust ( Site 2601)
RECRUITINGWithington, Manchester, M20 4BX, United Kingdom
-
The West Clinic, P.C. ( Site 0115)
RECRUITINGGermantown, Tennessee, 38138, United States
-
Trakya University Medical Faculty Hospital ( Site 2502)
RECRUITINGEdirne, 22030, Turkey (Türkiye)
-
Universitätsklinikum Jena ( Site 1313)
RECRUITINGJena, Thuringia, 07747, Germany
-
klinikum rechts der isar der technischen universität münchen ( Site 1315)
RECRUITINGMunich, Bavaria, 81675, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple blood draw may spot kidney cancer early
- Personalized vaccine trains immune system to attack kidney cancer blood vessels
- New kidney cancer drug shows promise in early trial
- New hope for advanced kidney cancer: belzutifan takes on everolimus in major trial
- New hope for advanced kidney cancer: Triple-Drug combo shows promise
- New drug cocktail aims to fight advanced cancers